These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32308186)

  • 1. An immunoproteomics approach to identify
    Machado AS; Ramos FF; Oliveira-da-Silva JA; Santos TTO; Tavares GSV; Costa LE; Lage DP; Teixeira-Ferreira A; Perales J; Fernandes AP; Moreira RLF; Duarte MC; Tupinambás U; Caligiorne RB; Cota GF; Coelho EAF; Ludolf F
    Parasitology; 2020 Aug; 147(9):932-939. PubMed ID: 32308186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of a recombinant protein from Leishmania infantum as a novel tool for Visceral Leishmaniasis (VL) diagnosis in VL/HIV co-infection cases.
    Ramos REM; Santos WJT; Magalhães FB; Diniz GTN; Costa CHN; de Melo Neto OP; Medeiros ZM; Reis CRS
    PLoS One; 2021; 16(5):e0251861. PubMed ID: 33999968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening diagnostic candidates from
    Lage DP; Ludolf F; Silveira PC; Machado AS; Ramos FF; Dias DS; Ribeiro PAF; Costa LE; Vale DL; Tavares GSV; Martins VT; Chávez-Fumagalli MA; Caligiorne RB; Chaves AT; Gonçalves DU; Rocha MOC; Duarte MC; Coelho EAF
    Parasitology; 2019 Sep; 146(11):1467-1476. PubMed ID: 31142384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of immunodominant proteins of Leishmania infantum by immunoproteomics to evaluate a recombinant multi-epitope designed antigen for serodiagnosis of human visceral leishmaniasis.
    Heidari S; Hajjaran H; Kazemi B; Gharechahi J; Mohebali M; Ranjbar MM; Akhoundi B; Azarian B; Mirshahvaladi S; Raoofian R
    Exp Parasitol; 2021 Mar; 222():108065. PubMed ID: 33428893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of subclinical Leishmania infection among HIV-infected patients living in the endemic areas of visceral leishmaniasis in Fars province, southern Iran.
    Rezaei Z; Sarkari B; Dehghani M; Layegh Gigloo A; Afrashteh M
    Parasitol Res; 2018 Aug; 117(8):2591-2595. PubMed ID: 29860572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfection.
    Galvani NC; Machado AS; Lage DP; Freitas CS; Vale DL; de Oliveira D; Ludolf F; Ramos FF; Fernandes BB; Luiz GP; Mendonça DVC; Oliveira-da-Silva JA; Reis TAR; Tavares GSV; Chaves AT; Guimarães NS; Tupinambás U; Cota GF; Humbert MV; Martins VT; Christodoulides M; Coelho EAF; Machado-de-Ávila RA
    Parasitol Res; 2021 Dec; 120(12):4037-4047. PubMed ID: 34664113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of recombinant LiHyQ, a novel Leishmania infantum protein, for the diagnosis of canine visceral leishmaniasis and as a diagnostic and prognostic marker for human leishmaniasis and human immunodeficiency virus co-infection: A preliminary study.
    Santos TTO; Ramos FF; Gonçalves IAP; Tavares GSV; Ludolf F; Bandeira RS; Silva AM; Oliveira-da-Silva JA; Reis TAR; Machado AS; Lage DP; Freitas CS; Vale DL; Martins VT; Alves LA; Guimarães NS; Chaves AT; Chávez-Fumagalli MA; Cota GF; Silveira JAG; Tupinambás U; Gonçalves DU; Christodoulides M; Coelho EAF
    Acta Trop; 2021 Dec; 224():106126. PubMed ID: 34537185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasis.
    Oliveira-da-Silva JA; Machado AS; Ramos FF; Tavares GSV; Lage DP; Ludolf F; Steiner BT; Reis TAR; Santos TTO; Costa LE; Martins VT; Galvani NC; Chaves AT; Oliveira JS; Chávez-Fumagalli MA; de Magalhães-Soares DF; Duarte MC; Menezes-Souza D; Silveira JAG; Moreira RLF; Machado-de-Ávila RA; Tupinambás U; Gonçalves DU; Coelho EAF
    Immunol Lett; 2020 Apr; 220():11-20. PubMed ID: 31981576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human disease.
    Machado AS; Ramos FF; Santos TTO; Costa LE; Ludolf F; Lage DP; Bandeira RS; Tavares GSV; Oliveira-da-Silva JA; Steiner BT; Chaves AT; Oliveira JS; Chávez-Fumagalli MA; de Magalhães-Soares DF; Silveira JAG; Duarte MC; Machado-de-Ávila RA; Lyon S; Gonçalves DU; Caligiorne RB; Coelho EAF
    Exp Parasitol; 2020 Sep; 216():107941. PubMed ID: 32622940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Multiplexed Assay for Detection of
    Abeijon C; Alves F; Monnerat S; Wasunna M; Mbui J; Viana AG; Bueno LL; Siqueira WF; Carvalho SG; Agrawal N; Fujiwara R; Sundar S; Campos-Neto A
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30787142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Leishmania eukaryotic elongation factor-1 beta protein: A potential diagnostic antigen to detect tegumentary and visceral leishmaniasis in dogs and humans.
    Santos TTO; Cardoso MS; Machado AS; Siqueira WF; Ramos FF; Oliveira-da-Silva JA; Tavares GSV; Lage DP; Costa LE; de Freitas CS; Martins VT; Bandeira RS; Chávez-Fumagalli MA; Lyon S; Moreira RLF; de Magalhães-Soares DF; Silveira JAG; Tupinambás U; Caligiorne RB; Chaves AT; Rocha MOC; Fujiwara RT; Coelho EAF
    Microb Pathog; 2019 Dec; 137():103783. PubMed ID: 31600536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic application of sensitive and specific phage-exposed epitopes for visceral leishmaniasis and human immunodeficiency virus coinfection.
    Ramos FF; Tavares GSV; Ludolf F; Machado AS; Santos TTO; Gonçalves IAP; Dias ACS; Alves PT; Fraga VG; Bandeira RS; Oliveira-da-Silva JA; Reis TAR; Lage DP; Martins VT; Freitas CS; Chaves AT; Guimarães NS; Chávez-Fumagalli MA; Tupinambás U; Rocha MOC; Cota GF; Fujiwara RT; Bueno LL; Goulart LR; Coelho EAF
    Parasitology; 2021 Nov; 148(13):1706-1714. PubMed ID: 35060464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Leishmania infantum hypothetical protein evaluated as a recombinant protein and specific B-cell epitope for the serodiagnosis and prognosis of visceral leishmaniasis.
    Machado AS; Ramos FF; Oliveira-da-Silva JA; Santos TTO; Ludolf F; Tavares GSV; Costa LE; Lage DP; Steiner BT; Chaves AT; Chávez-Fumagalli MA; de Magalhães-Soares DF; Silveira JAG; Napoles KMN; Tupinambás U; Duarte MC; Machado-de-Ávila RA; Bueno LL; Fujiwara RT; Moreira RLF; Rocha MOC; Caligiorne RB; Coelho EAF
    Acta Trop; 2020 Mar; 203():105318. PubMed ID: 31870709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical aspects of visceral leishmaniasis caused by L. infantum in adults. Ten years of experience of the largest outbreak in Europe: what have we learned?
    Horrillo L; Castro A; Matía B; Molina L; García-Martínez J; Jaqueti J; García-Arata I; Carrillo E; Moreno J; Ruiz-Giardin JM; San Martín J
    Parasit Vectors; 2019 Jul; 12(1):359. PubMed ID: 31340851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymptomatic carriers of Leishmania infantum in patients infected with human immunodeficiency virus (HIV) in Morocco.
    Echchakery M; Nieto J; Boussaa S; El Fajali N; Ortega S; Souhail K; Aajly H; Chicharro C; Carrillo E; Moreno J; Boumezzough A
    Parasitol Res; 2018 Apr; 117(4):1237-1244. PubMed ID: 29478175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenicity of phage clones and their synthetic peptides for the serodiagnosis of canine and human visceral leishmaniasis.
    Costa LE; Salles BCS; Santos TTO; Ramos FF; Lima MP; Lima MIS; Portela ÁSB; Chávez-Fumagalli MA; Duarte MC; Menezes-Souza D; Machado-de-Ávila RA; Silveira JAG; Magalhães-Soares DF; Goulart LR; Coelho EAF
    Microb Pathog; 2017 Sep; 110():14-22. PubMed ID: 28629727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and diagnostic utility of Leishmania infantum proteins found in urine samples from patients with visceral leishmaniasis.
    Abeijon C; Kashino SS; Silva FO; Costa DL; Fujiwara RT; Costa CH; Campos-Neto A
    Clin Vaccine Immunol; 2012 Jun; 19(6):935-43. PubMed ID: 22518013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of asymptomatic and symptomatic humans as reservoirs of visceral leishmaniasis in a Mediterranean context.
    Molina R; Jiménez M; García-Martínez J; San Martín JV; Carrillo E; Sánchez C; Moreno J; Alves F; Alvar J
    PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008253. PubMed ID: 32324738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis.
    Boarino A; Scalone A; Gradoni L; Ferroglio E; Vitale F; Zanatta R; Giuffrida MG; Rosati S
    Clin Diagn Lab Immunol; 2005 May; 12(5):647-53. PubMed ID: 15879027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential application of small myristoylated protein-3 evaluated as recombinant antigen and a synthetic peptide containing its linear B-cell epitope for the serodiagnosis of canine visceral and human tegumentary leishmaniasis.
    Salles BCS; Dias DS; Steiner BT; Lage DP; Ramos FF; Ribeiro PAF; Santos TTO; Lima MP; Costa LE; Chaves AT; Chávez-Fumagalli MA; Fujiwaraa RT; Buenoa LL; Caligiorne RB; de Magalhães-Soares DF; Silveira JAG; Machado-de-Ávila RA; Gonçalves DU; Coelho EAF
    Immunobiology; 2019 Jan; 224(1):163-171. PubMed ID: 30266201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.